TyraTech
<< < > >>
Search:
 
| Full PDF report | Print this page |
Annual Report & Accounts 2010 - Financial Review
slide
<< < > >>
In October 2008, Molecular Securities, Inc. (Molecular) filed a complaint against the Company asserting claims for breach of contract. Molecular alleges that it is owed US$ 2.7 million for services that it allegedly provided to TyraTech plus interest, attorneys' fees and costs. The Company strongly refutes this claim and is vigorously defending itself in the lawsuit. After taking advice on the merits and demerits of the lawsuit the Company does not intend to provide any liability for the lawsuit. On 26 May 2011, the New York Supreme Court, Appellate Division of New York County issued a ruling entering judgment in favour of the Company and against Molecular and dismissing Molecular's complaint in its entirety. Molecular may choose to appeal the ruling with the Court of Appeals (New York's highest court) in which case the Company will continue to defend itself and continues to believe that the recording of any liability is inappropriate as Molecular's claims are meritless. If Molecular were to prevail in the litigation there could be a material adverse effect upon the Group's working capital which could in turn significantly delay the development of the Group's business and its ability to achieve profitability. Currency Effects : The Group has no significant overseas currency exposures and does not use financial derivatives to manage currency risk. Peter Jerome, Chief Financial Officer and Group Secretary 20 June 2011 11 T y r a T e c h , I n c . : A n n u a l R e p o r t 2 0 1 0